Credit rating agency -- Acuite has upgraded credit ratings of Bal Pharma. Long Term Fund based facilities has been upgraded to ‘BBB-’ stable from ‘BB+’ positive. Short term Non fund based facilities has been upgraded to ‘A3’ from ‘A4+’. Also, Long term-Term Loan has been upgraded to ‘BBB-’ stable from ‘BB+’ positive.
Bal Pharma, incorporated in 1987 is engaged in the business interest in area of manufacturing API, finished formulations, ayurvedic and research and development. It is one of the leading Indian pharmaceutical companies that focuses on prescription drugs, generic, OTC products, intravenous infusion and bulk actives.
